Literature DB >> 19996116

Granulocyte transfusion therapy: randomization after all?

Agata Drewniak, Taco W Kuijpers.   

Abstract

Mesh：

Year:  2009        PMID： 19996116      PMCID： PMC2791939          DOI： 10.3324/haematol.2009.013680

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  28 in total

1.  Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.

Authors:  Aarti Oza; Chris Hallemeier; Lawrence Goodnough; Hanna Khoury; Shalini Shenoy; Steven Devine; Kristan Augustin; Ravi Vij; Kathryn Trinkaus; John F Dipersio; Douglas Adkins
Journal:  Transfusion       Date:  2006-01       Impact factor: 3.157

2.  Granulocyte transfusions in severe aplastic anemia: an eleven-year experience.

Authors:  Karen Quillen; Edward Wong; Phillip Scheinberg; Neal S Young; Thomas J Walsh; Colin O Wu; Susan F Leitman
Journal:  Haematologica       Date:  2009-12       Impact factor: 9.941

Review 3.  Granulocyte transfusions in neutropaenic children: a systematic review of the literature.

Authors:  M D van de Wetering; N Weggelaar; M Offringa; H N Caron; T W Kuijpers
Journal:  Eur J Cancer       Date:  2007-08-29       Impact factor: 9.162

4.  Randomized phase III study of granulocyte transfusions in neutropenic patients.

Authors:  M G Seidel; C Peters; A Wacker; H Northoff; R Moog; A Boehme; G Silling; W Grimminger; H Einsele
Journal:  Bone Marrow Transplant       Date:  2008-08-11       Impact factor: 5.483

5.  Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions.

Authors:  Y Ofran; I Avivi; A Oliven; I Oren; T Zuckerman; L Bonstein; J M Rowe; E J Dann
Journal:  Vox Sang       Date:  2007-11       Impact factor: 2.144

Review 6.  Granulocyte transfusions in neutropenic patients: beneficial effects proven?

Authors:  C Peters
Journal:  Vox Sang       Date:  2009-01-29       Impact factor: 2.144

7.  Changes in gene expression of granulocytes during in vivo granulocyte colony-stimulating factor/dexamethasone mobilization for transfusion purposes.

Authors:  Agata Drewniak; Bram J van Raam; Judy Geissler; Anton T J Tool; Olaf R F Mook; Timo K van den Berg; Frank Baas; Taco W Kuijpers
Journal:  Blood       Date:  2009-04-06       Impact factor: 22.113

8.  Granulocyte concentrates: prolonged functional capacity during storage in the presence of phenotypic changes.

Authors:  Agata Drewniak; Jaap-Jan Boelens; Hans Vrielink; Anton T J Tool; Marrie C A Bruin; Marry van den Heuvel-Eibrink; Lynne Ball; Marianne D van de Wetering; Dirk Roos; Taco W Kuijpers
Journal:  Haematologica       Date:  2008-05-27       Impact factor: 9.941

9.  Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.

Authors:  Karen Quillen; Phyllis Byrne; Yu Ying Yau; Susan F Leitman
Journal:  Transfusion       Date:  2009-03       Impact factor: 3.157

Review 10.  Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction.

Authors:  Edwin Massey; Ulrike Paulus; Carolyn Doree; Simon Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more
  8 in total

Review 1.  Supportive care in patients with acute leukaemia: historical perspectives.

Authors:  Giovanna Cannas; Xavier Thomas
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

Review 2.  Development of autologous blood cell therapies.

Authors:  Ah Ram Kim; Vijay G Sankaran
Journal:  Exp Hematol       Date:  2016-06-21       Impact factor: 3.084

3.  Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components.

Authors:  Roel P Gazendam; Annemarie van de Geer; John L van Hamme; Anton T J Tool; Dieke J van Rees; Cathelijn E M Aarts; Maartje van den Biggelaar; Floris van Alphen; Paul Verkuijlen; Alexander B Meijer; Hans Janssen; Dirk Roos; Timo K van den Berg; Taco W Kuijpers
Journal:  Haematologica       Date:  2016-01-22       Impact factor: 9.941

4.  Membrane permeability of the human granulocyte to water, dimethyl sulfoxide, glycerol, propylene glycol and ethylene glycol.

Authors:  Alex M Vian; Adam Z Higgins
Journal:  Cryobiology       Date:  2013-11-20       Impact factor: 2.487

5.  Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: Experience from a tertiary care centre in North India.

Authors:  Akanksha Garg; Anshul Gupta; Ashish Mishra; Manoj Singh; Sanjeev Yadav; Soniya Nityanand
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

6.  Risk stratification by 30-day prognostic factors of clinical outcomes after granulocyte transfusion in acute myeloid leukemia: A single-center retrospective study.

Authors:  Jaeeun Yoo; Hyung Suk Cho; Jae-Ho Yoon; Byung Sik Cho; Hee-Je Kim; Dong-Gun Lee; Dong Wook Jekarl; Myungshin Kim; Eun-Jee Oh; Yeon-Joon Park; Yonggoo Kim
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

Review 7.  Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Asma M Al-Jasser
Journal:  Front Oncol       Date:  2014-07-14       Impact factor: 6.244

8.  Young donor white blood cell immunotherapy induces extensive tumor necrosis in advanced-stage solid tumors.

Authors:  Dipnarine Maharaj; Pedro G Vianna; Wendy Ward; Anthony J Messina; Trevor Rayborn; Jacqueline V Gouvea; Richard D Hammer; Zheng Cui
Journal:  Heliyon       Date:  2017-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.